✓ Medically reviewed by Dr. Anjmun Sharma, MD · Updated 2026-06-023 min read

GLP-1 Medications and Heart Rate: Is a Small Increase Normal?

A modest rise in resting heart rate is recognized. Here is what it means and when to report it.

An adult doing a light resistance workout at home in natural light

The short answer

GLP-1 medications can cause a small increase in resting heart rate (often a few beats per minute on average). For most people this is modest and not dangerous, and it is separate from the cardiovascular benefits semaglutide showed in the SELECT trial (PMID 37952131). Still, palpitations or a noticeably fast heartbeat are worth reporting.

Why it happens

This mild heart-rate effect is a recognized property of GLP-1 medications. It is usually small and well tolerated. It does not cancel out the heart benefits seen in trials, where semaglutide reduced cardiovascular events in a specific high-risk population, but it is something clinicians keep an eye on.

Ready to start?

$199 Skeptics’ Trial, see if it works for you

One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.

Start the 30-day trial

What to watch for

Tell your physician if you feel a racing or pounding heartbeat, palpitations, chest discomfort, or shortness of breath, or if you have a known heart-rhythm condition. They can monitor your heart rate and decide whether any change to the plan is needed.

How this relates to what we offer

Our review covers heart history, and follow-up lets us monitor how you respond rather than starting a medication and walking away.

What you can start today at New Hope Weight Loss

After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality. In person in Orange County and by telehealth across California and additional states.

Ready for an honest, physician-supervised plan?

A $119 review with Dr. Sharma is the first step, no pressure. Take the 2-minute quiz or call us.

Call (657) 837-3342

Frequently asked questions

Do GLP-1 medications raise heart rate?

They can cause a small increase in resting heart rate, often a few beats per minute on average. For most people it is modest and well tolerated, but report palpitations or a noticeably fast heartbeat.

Is the heart-rate increase dangerous?

For most people it is modest and not dangerous. People with heart-rhythm conditions need physician oversight. Report palpitations, chest discomfort, or shortness of breath.

Doesn't semaglutide help the heart?

Yes, in the SELECT trial (PMID 37952131) semaglutide reduced cardiovascular events in a specific high-risk population. The mild resting heart-rate effect is separate and usually minor.

Should I check my pulse on a GLP-1?

If you have a heart condition or feel palpitations, mention it so your physician can monitor. Routine concern is low for most people, but reporting symptoms is wise.

Does New Hope review heart history?

Yes. Our review covers heart history, and follow-up lets us monitor your response rather than starting a medication and walking away.

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.

Not ready to start? Get the details by email.

Pricing, how it works, and what to expect, sent to your inbox. No pressure, unsubscribe anytime.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.